1. Home >
  2. Companies >
  3. Public >
  4. Life Science >
  5. Japan >
  6. Sumitomo Pharma >
  7. M&A

Sumitomo Pharma Mergers & Acquisitions

Sumitomo Pharma M&A Summary

Sumitomo Pharma has acquired 1 company. It has also divested 1 asset.

Sumitomo Pharma’s largest acquisition to date was in 2009, when it acquired Sunovion Pharmaceuticals. for $2.6B. Sumitomo Pharma has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity1
    • M&A Sell Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 1

Sumitomo Pharma

Sumitomo Pharma Co. Ltd.

6-8 Doshomachi 2-chome Chuo-ku,
Osaka, 541-0045
Japan,
81 6 6203 5321
www.sumitomo-pharma.com

All (2) Buy (1) Sell (1)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2022-12-26 Sumitomo Pharma AH · Consumer Services
Osaka, Japan · ah.sumitomo-pharma.co.jp

Sumitomo Pharma AH is a Japanese animal health company that leverages its advanced product development capabilities accumulated as a subsidiary of a pharmaceutical manufacturer to develop, manufacture, and sell veterinary medicines for companion animals and livestock, especially in Japan. Sumitomo Pharma AH is based in Osaka, Japan.

- Divestiture

Mitsui & Co

Sumitomo Pharma


Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal